Designing Work That Actually Works

Designing Work That Actually Works

Designing Work That Actually Works The Future of Neurodiversity at Work in 2026 As we move into 2026, neurodiversity at work has shifted from the margins to the centre of serious organisational conversations. This is no longer about goodwill or workplace trends....
When the elephant finally moves

When the elephant finally moves

When the Elephant Finally Moves Why Neurodiversity Must Shape How We Understand Risk at Work In my article “Psychosocial Risk and Neurodiversity: The Elephant in the Room” published on LinkedIn on 7 November, I explained why neurodiversity must be at the heart of...
Four Years On Reflections on The Neurodiverse Safe Work Initiative and the Road Ahead

Four Years On Reflections on The Neurodiverse Safe Work Initiative and the Road Ahead

As the Neurodiverse Safe Work Initiative celebrates its fourth anniversary, I find myself reflecting not just on how far we’ve come, but on how much the conversation around neurodiversity at work has matured, in awareness, practice, policy, and opportunity. It’s been...
Why the White House’s Position on Autism and ADHD, Tylenol and Vaccines is Misguided and Dangerous

Why the White House’s Position on Autism and ADHD, Tylenol and Vaccines is Misguided and Dangerous

The United States (US) White House made headlines on 23 September 2025 with a statement that it had achieved “major progress in understanding the root causes of autism.” The announcement pointed the finger at acetaminophen (commonly known as Panadol or Tylenol) during...